-
Je něco špatně v tomto záznamu ?
Outcome of Repeat Venoarterial Extracorporeal Membrane Oxygenation in Postcardiotomy Cardiogenic Shock
H. Yusuff, F. Biancari, K. Jónsson, S. Ragnarsson, M. Dalén, T. Fux, AM. Dell'Aquila, A. Fiore, DD. Perna, G. Gatti, M. Gabrielli, T. Juvonen, S. Zipfel, K. Bounader, A. Perrotti, A. Loforte, A. Lechiancole, M. Pol, M. Pettinari, D. De Keyzer, H....
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, multicentrická studie
- MeSH
- dospělí MeSH
- kardiogenní šok etiologie terapie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mimotělní membránová oxygenace * škodlivé účinky MeSH
- mortalita v nemocnicích MeSH
- registrace MeSH
- retrospektivní studie MeSH
- senioři MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
OBJECTIVE: Data on patients requiring a second run of venoarterial extracorporeal membrane oxygenation (VA-ECMO) support in patients affected by postcardiotomy cardiogenic shock (PCS) are very limited. The authors aimed to investigate the effect of a second run of VA-ECMO on PCS patient survival. DESIGN: Retrospective analysis of an international registry. SETTING: Multicenter study, tertiary university hospitals. PARTICIPANTS: Data on adult PCS patients receiving a second run of VA-ECMO. MEASUREMENTS AND MAIN RESULTS: A total of 674 patients with a mean age of 62.9 ± 12.7 years were analyzed, and 21 (3.1%) patients had a second run of VA-ECMO. None of them required more than two VA-ECMO runs. The median duration of VA-ECMO therapy was 135 hours (interquartile range [IQR] 61-226) in patients who did not require a VA-ECMO rerun. In the rerun VA-ECMO group the median overall duration of VA-ECMO therapy was 183 hours (IQR 107-344), and the median duration of the first run was 114 hours (IQR 66-169). Nine (42.9%) of the patients who required a second run of VA-ECMO died during VA-ECMO therapy, whereas five (23.8%) survived to hospital discharge. No differences between patients treated with single or second VA-ECMO runs were observed in terms of hospital mortality and late survival. In patients requiring a second VA-ECMO run, the actuarial survival estimates at three and 12 months after VA-ECMO weaning were 23.8% ± 9.3% and 19.6% ± 6.4%, respectively. CONCLUSIONS: Repeat VA-ECMO therapy is a valid treatment strategy for PCS patients. Early and late survivals are similar between patients who have undergone a single or second run of VA-ECMO.
Cardiac Surgery S Anna Hospital Catanzaro Italy
Cardiothoracic Department University Hospital of Udine Udine Italy
Department of Cardiac Surgery Sahlgrenska University Hospital Gothenburg Sweden
Department of Cardiothoracic Surgery Münster University Hospital Münster Germany
Department of Cardiothoracic Surgery University of Lund Lund Sweden
Department of Cardiovascular Surgery Ziekenhuis Oost Limburg Genk Belgium
Department of Surgery University of Turku Turku Finland
Department of Thoracic and Cardio Vascular Surgery University Hospital Jean Minjoz Besançon France
Division of Cardiac Surgery IRCCS Azienda Ospedaliero Universitaria di Bologna Bologna Italy
Division of Cardiac Surgery Ospedali Riuniti Trieste Italy
Division of Cardiothoracic and Vascular Surgery Pontchaillou University Hospital Rennes France
Division of Cardiothoracic and Vascular Surgery Robert Debré University Hospital Reims France
Hamburg University Heart Center Hamburg Germany
Heart and Lung Center Helsinki University Hospital University of Helsinki Helsinki Finland
Institute of Clinical and Experimental Medicine Prague Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011824
- 003
- CZ-PrNML
- 005
- 20220506130012.0
- 007
- ta
- 008
- 220425s2021 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1053/j.jvca.2021.03.001 $2 doi
- 035 __
- $a (PubMed)33838979
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Yusuff, Hakeem $u Department of Intensive Care Medicine and Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom
- 245 10
- $a Outcome of Repeat Venoarterial Extracorporeal Membrane Oxygenation in Postcardiotomy Cardiogenic Shock / $c H. Yusuff, F. Biancari, K. Jónsson, S. Ragnarsson, M. Dalén, T. Fux, AM. Dell'Aquila, A. Fiore, DD. Perna, G. Gatti, M. Gabrielli, T. Juvonen, S. Zipfel, K. Bounader, A. Perrotti, A. Loforte, A. Lechiancole, M. Pol, M. Pettinari, D. De Keyzer, H. Welp, D. Maselli, K. Alkhamees, VG. Ruggieri, G. Mariscalco
- 520 9_
- $a OBJECTIVE: Data on patients requiring a second run of venoarterial extracorporeal membrane oxygenation (VA-ECMO) support in patients affected by postcardiotomy cardiogenic shock (PCS) are very limited. The authors aimed to investigate the effect of a second run of VA-ECMO on PCS patient survival. DESIGN: Retrospective analysis of an international registry. SETTING: Multicenter study, tertiary university hospitals. PARTICIPANTS: Data on adult PCS patients receiving a second run of VA-ECMO. MEASUREMENTS AND MAIN RESULTS: A total of 674 patients with a mean age of 62.9 ± 12.7 years were analyzed, and 21 (3.1%) patients had a second run of VA-ECMO. None of them required more than two VA-ECMO runs. The median duration of VA-ECMO therapy was 135 hours (interquartile range [IQR] 61-226) in patients who did not require a VA-ECMO rerun. In the rerun VA-ECMO group the median overall duration of VA-ECMO therapy was 183 hours (IQR 107-344), and the median duration of the first run was 114 hours (IQR 66-169). Nine (42.9%) of the patients who required a second run of VA-ECMO died during VA-ECMO therapy, whereas five (23.8%) survived to hospital discharge. No differences between patients treated with single or second VA-ECMO runs were observed in terms of hospital mortality and late survival. In patients requiring a second VA-ECMO run, the actuarial survival estimates at three and 12 months after VA-ECMO weaning were 23.8% ± 9.3% and 19.6% ± 6.4%, respectively. CONCLUSIONS: Repeat VA-ECMO therapy is a valid treatment strategy for PCS patients. Early and late survivals are similar between patients who have undergone a single or second run of VA-ECMO.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a mimotělní membránová oxygenace $x škodlivé účinky $7 D015199
- 650 _2
- $a mortalita v nemocnicích $7 D017052
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a registrace $7 D012042
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a kardiogenní šok $x etiologie $x terapie $7 D012770
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Biancari, Fausto $u Research Unit of Surgery, Anesthesiology and Critical Care, Faculty of Medicine, University of Oulu, Oulu, Finland; Department of Surgery, University of Turku, Turku, Finland; Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
- 700 1_
- $a Jónsson, Kristján $u Department of Cardiac Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden
- 700 1_
- $a Ragnarsson, Sigurdur $u Department of Cardiothoracic Surgery, University of Lund, Lund, Sweden
- 700 1_
- $a Dalén, Magnus $u Department of Molecular Medicine and Surgery, Department of Cardiac Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Fux, Thomas $u Department of Molecular Medicine and Surgery, Department of Cardiac Surgery, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
- 700 1_
- $a Dell'Aquila, Angelo M $u Department of Cardiothoracic Surgery, Münster University Hospital, Münster, Germany
- 700 1_
- $a Fiore, Antonio $u Department of Cardiothoracic Surgery, Henri Mondor University Hospital, AP-HP, Paris-Est University, Créteil, France
- 700 1_
- $a Perna, Dario Di $u Division of Cardiothoracic and Vascular Surgery, Robert Debré University Hospital, Reims, France
- 700 1_
- $a Gatti, Giuseppe $u Division of Cardiac Surgery, Ospedali Riuniti, Trieste, Italy
- 700 1_
- $a Gabrielli, Marco $u Division of Cardiac Surgery, Ospedali Riuniti, Trieste, Italy
- 700 1_
- $a Juvonen, Tatu $u Research Unit of Surgery, Anesthesiology and Critical Care, Faculty of Medicine, University of Oulu, Oulu, Finland; Heart and Lung Center, Helsinki University Hospital, University of Helsinki, Helsinki, Finland
- 700 1_
- $a Zipfel, Svante $u Hamburg University Heart Center, Hamburg, Germany; Division of Cardiothoracic and Vascular Surgery, Pontchaillou University Hospital, Rennes, France
- 700 1_
- $a Bounader, Karl $u Hamburg University Heart Center, Hamburg, Germany; Division of Cardiothoracic and Vascular Surgery, Pontchaillou University Hospital, Rennes, France
- 700 1_
- $a Perrotti, Andrea $u Department of Thoracic and Cardio-Vascular Surgery, University Hospital Jean Minjoz, Besançon, France
- 700 1_
- $a Loforte, Antonio $u Division of Cardiac Surgery, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy
- 700 1_
- $a Lechiancole, Andrea $u Cardiothoracic Department, University Hospital of Udine, Udine, Italy
- 700 1_
- $a Pol, Marek $u Institute of Clinical and Experimental Medicine, Prague, Czech Republic
- 700 1_
- $a Pettinari, Matteo $u Department of Cardiovascular Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium
- 700 1_
- $a De Keyzer, Dieter $u Department of Cardiovascular Surgery, Ziekenhuis Oost-Limburg, Genk, Belgium
- 700 1_
- $a Welp, Henryk $u Department of Cardiothoracic Surgery, Münster University Hospital, Münster, Germany
- 700 1_
- $a Maselli, Daniele $u Cardiac Surgery, S. Anna Hospital, Catanzaro, Italy
- 700 1_
- $a Alkhamees, Khalid $u Prince Sultan Cardiac Center, Al Hassa, Saudi Arabia
- 700 1_
- $a Ruggieri, Vito G $u Division of Cardiothoracic and Vascular Surgery, Robert Debré University Hospital, Reims, France
- 700 1_
- $a Mariscalco, Giovanni $u Department of Intensive Care Medicine and Cardiac Surgery, Glenfield Hospital, University Hospitals of Leicester NHS Trust, Leicester, United Kingdom. Electronic address: giovannimariscalco@yahoo.it
- 773 0_
- $w MED00002568 $t Journal of cardiothoracic and vascular anesthesia $x 1532-8422 $g Roč. 35, č. 12 (2021), s. 3620-3625
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/33838979 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130004 $b ABA008
- 999 __
- $a ok $b bmc $g 1789432 $s 1163025
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2021 $b 35 $c 12 $d 3620-3625 $e 20210306 $i 1532-8422 $m Journal of cardiothoracic and vascular anesthesia $n J Cardiovasc Vasc Anesth $x MED00002568
- LZP __
- $a Pubmed-20220425
